These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
654 related articles for article (PubMed ID: 17561313)
1. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains. Amritraj A; Hawkes C; Phinney AL; Mount HT; Scott CD; Westaway D; Kar S Neurobiol Aging; 2009 Jan; 30(1):54-70. PubMed ID: 17561313 [TBL] [Abstract][Full Text] [Related]
2. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology. Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207 [TBL] [Abstract][Full Text] [Related]
3. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589 [TBL] [Abstract][Full Text] [Related]
4. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Kurt MA; Davies DC; Kidd M; Duff K; Rolph SC; Jennings KH; Howlett DR Exp Neurol; 2001 Sep; 171(1):59-71. PubMed ID: 11520121 [TBL] [Abstract][Full Text] [Related]
5. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
6. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy. Miettinen R; Riedel A; Kalesnykas G; Kettunen HP; Puoliväli J; Soininen H; Arendt T J Chem Neuroanat; 2005 Oct; 30(2-3):105-18. PubMed ID: 16081247 [TBL] [Abstract][Full Text] [Related]
7. Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice. Dhenain M; El Tannir El Tayara N; Wu TD; Guégan M; Volk A; Quintana C; Delatour B Neurobiol Aging; 2009 Jan; 30(1):41-53. PubMed ID: 17588710 [TBL] [Abstract][Full Text] [Related]
8. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS. Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation. Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932 [TBL] [Abstract][Full Text] [Related]
10. Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease. Wirths O; Weis J; Szczygielski J; Multhaup G; Bayer TA Acta Neuropathol; 2006 Apr; 111(4):312-9. PubMed ID: 16520967 [TBL] [Abstract][Full Text] [Related]
11. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Jankowsky JL; Slunt HH; Gonzales V; Jenkins NA; Copeland NG; Borchelt DR Neurobiol Aging; 2004 Aug; 25(7):885-92. PubMed ID: 15212842 [TBL] [Abstract][Full Text] [Related]
12. Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice. Puoliväli J; Wang J; Heikkinen T; Heikkilä M; Tapiola T; van Groen T; Tanila H Neurobiol Dis; 2002 Apr; 9(3):339-47. PubMed ID: 11950278 [TBL] [Abstract][Full Text] [Related]
13. The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system. Hawkes C; Kar S Brain Res Brain Res Rev; 2004 Mar; 44(2-3):117-40. PubMed ID: 15003389 [TBL] [Abstract][Full Text] [Related]
14. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein. Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629 [TBL] [Abstract][Full Text] [Related]
15. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. El Tannir El Tayara N; Delatour B; Le Cudennec C; Guégan M; Volk A; Dhenain M Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice. Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020 [TBL] [Abstract][Full Text] [Related]
17. Presenilin 1-related alterations in DNA integrity in a transgenic mouse model of Alzheimer's disease. Michelsen KA; Korr H; Steinbusch HW; Schmitz C Brain Res; 2010 Feb; 1316():139-44. PubMed ID: 20034479 [TBL] [Abstract][Full Text] [Related]
18. Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency. Stoltenberg M; Bush AI; Bach G; Smidt K; Larsen A; Rungby J; Lund S; Doering P; Danscher G Neuroscience; 2007 Dec; 150(2):357-69. PubMed ID: 17949919 [TBL] [Abstract][Full Text] [Related]
19. Changes in bladder innervation in a mouse model of Alzheimer's disease. Biallosterski BT; de Wachter SG; van Koeveringe GA; van Kerrebroeck PE; de Vente J; Mulder MT; Gillespie JI J Chem Neuroanat; 2010 May; 39(3):204-10. PubMed ID: 20025962 [TBL] [Abstract][Full Text] [Related]
20. Enhanced accumulation of tau in doubly transgenic mice expressing mutant betaAPP and presenilin-1. Samura E; Shoji M; Kawarabayashi T; Sasaki A; Matsubara E; Murakami T; Wuhua X; Tamura S; Ikeda M; Ishiguro K; Saido TC; Westaway D; St George Hyslop P; Harigaya Y; Abe K Brain Res; 2006 Jun; 1094(1):192-9. PubMed ID: 16713590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]